Microcap Ledger LENSAR, Inc. $LNSR
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Orlando, FL
- Fiscal year end
- December 31
- Shares outstanding
- 12,285,865 [10-Q 2026-08-13]
What the company doesAI summary of filing
LENSAR, Inc. is a commercial-stage medical device company that designs, develops, and markets laser systems for cataract surgery and management of corneal astigmatism. The company generates revenue from the sale and lease of its laser systems (the LENSAR Laser System and ALLY Robotic Cataract Laser System), associated procedure licenses, and consumables. The ALLY System received FDA clearance in June 2022 and is available in the United States, European Union, and select other countries including India, Taiwan, and South Korea. As of December 31, 2025, the company had approximately 435 systems installed across 17 countries, with approximately 51% in the United States. [10-K 2026-03-31]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $29.92M | $39.87M | −$4.40M | $13.56M | [10-Q 2026-08-13] |
| FY ended Dec 2025 | $58.44M | −$34.28M | −$14.83M | $12.97M | [10-K 2026-03-31] |
| FY ended Dec 2024 | $53.49M | −$31.40M | −$2.27M | $16.26M | [10-K 2026-03-31] |
- Quarterly cash burn
- −$2.20M
- Cash runway Estimate
- ~18.5 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-10-31 | 11,614,807 | [10-Q 2024-11-07] |
| 2025-01-31 | 11,789,492 | [10-K 2025-02-27] |
| 2025-04-28 | 11,792,156 | [10-Q 2025-05-08] |
| 2025-07-31 | 11,934,784 | [10-Q 2025-08-07] |
| 2025-10-24 | 11,944,546 | [10-Q 2025-11-06] |
| 2026-02-28 | 12,095,631 | [10-K 2026-03-31] |
| 2026-04-28 | 12,104,328 | [10-Q 2026-05-08] |
| 2026-07-31 | 12,285,865 | [10-Q 2026-08-13] |
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-06-03 | Hammer Todd B | grant | 17,421 | — | [4 2026-06-05] |
| 2026-06-03 | Ellis Thomas B | grant | 17,421 | — | [4 2026-06-05] |
| 2026-06-03 | Wong Kendra | grant | 13,066 | — | [4 2026-06-05] |
| 2026-06-03 | Connaughton Alan B. | grant | 34,843 | — | [4 2026-06-05] |
| 2026-06-03 | Curtis Nicholas T | grant | 130,662 | — | [4 2026-06-05] |
| 2026-06-03 | Weisner Aimee S | grant | 17,421 | — | [4 2026-06-05] |
| 2026-06-03 | O'Farrell Elizabeth G. | grant | 17,421 | — | [4 2026-06-05] |
| 2026-06-03 | Winer Gary M | grant | 17,421 | — | [4 2026-06-05] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-08-13 | 10-Q | Quarterly report |
| 2026-08-13 | 8-K | Results of operations |
| 2026-08-10 | 8-K | Shareholder vote results |
| 2026-07-29 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-06-23 | DEF 14A | Proxy statement |
| 2026-05-29 | 8-K | Director or officer change; Other events |
| 2026-05-14 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-05-08 | 10-Q | Quarterly report |
| 2026-05-08 | 8-K | Results of operations |
| 2026-04-30 | 10-K/A | Amended report |
| 2026-04-15 | 8-K | Director or officer change |
| 2026-03-31 | 10-K | Annual report |
Alerts for $LNSR
Email me when LENSAR, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.